NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.
Read Original Story

Study adds to evidence of vaccine safety

Rating

5 Star

Study adds to evidence of vaccine safety

Our Review Summary

The story does a reasonable job in describing the study as published in Pediatrics.  Although there are some lapses in the story, the report provides an adequate review of the study and its relative importance.  Although thimerosal has been reduced or removed in pediatric vaccines, the issue of autism and vaccines remains in the public memory.

The results of this study are reassuring from the view that they indicate that the levels of thimerosal which had previously been used in vaccines do not play a role in the development of autism. 

 Parents make decisions on the use of vaccines on an ongoing basis.  Although experts in infectious disease would argue there are really no options, parents do resist and refuse to appropriately vaccinate their children based on an unfounded fear of autism. 

Criteria

Does the story adequately discuss the costs of the intervention?

Not Applicable

The story was about thimerosal being reduced or eliminated from vaccines, so cost is not an issue in this context. 

Does the story adequately quantify the benefits of the treatment/test/product/procedure?

Not Applicable

The benefit of the pediatric vaccines was not the central issue of the story but rather the risks associated with their use. 

Does the story adequately explain/quantify the harms of the intervention?

Satisfactory

The study was intended to determine if a causal relationship could be attributed to the use of thimerosal in pediatric vaccines.  As such the theoretical harms of the vaccine are described correctly.  However, an important element missing in the story is the downside of not immunizing children.  The story would have been enhanced with a brief comment about the negative impact of avoiding immunization (including the use of influenza vaccine). 

Does the story seem to grasp the quality of the evidence?

Satisfactory

The story correctly describes the study design and the relative uniqueness of the methods used.  The conclusions of the study are appropriately noted in the report. 

Does the story commit disease-mongering?

Satisfactory

The story did not engage in overt disease mongering.

Does the story use independent sources and identify conflicts of interest?

Satisfactory

Two individuals with expertise in vaccines and with no connection to this study were interviewed as part of this story.

Does the story compare the new approach with existing alternatives?

Not Satisfactory

The story provided little or no information about decisions beyond simple ‘yes’ and ‘no’ concerning vaccination. 

This story reported on a study of two vaccines against the same disease with different levels of thimerosal.  So, for example, are there ever choices to be made about levels of other preservatives in vaccines?  The story did not provide information about the benefits or harms associated with vaccination in general.

Does the story establish the availability of the treatment/test/product/procedure?

Satisfactory

The story was about a study that compared outcomes in youngsters who had received vaccines with different levels of thimerosal.  The story correctly points out that since 2001, thimerosal has not been used as a preservative in pediatric vaccines in the US other than flu vccine. 

Does the story establish the true novelty of the approach?

Satisfactory

The story was about two vaccines for whooping cough with different levels of the preservative thimerosal.  The story also reported that the preservative thimerosal is no longer used in vaccines in the US.  Therefore, this story is about a treatment that is not available.  

 

Does the story appear to rely solely or largely on a news release?

Satisfactory

Does not appear to rely on a press release.

Total Score: 7 of 8 Satisfactory

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.